Keith Barnett

Keith Barnett has over 14 years of experience in the pharmaceutical industry, with expertise in clinical operations and program management. Keith is currently serving as the Senior Director and Head of Clinical Operations at Jounce Therapeutics, Inc. Prior to this role, they held the same position at Pandion Therapeutics, where they were responsible for overseeing clinical operations until the company's acquisition by Merck. Keith also worked as the Director of Clinical Operations and Program Management at Palatin Technologies for six years. Before that, they served as a Clinical Research Scientist and Global Vendor Lead at Actavis (now Allergan). Additionally, Keith gained experience as a Local Trial Manager at Janssen, a Clinical Trial Associate at Sanofi, and a Scientific Office Assistant at Novartis.

Keith Barnett, DrPH (c), MS, MBA, has completed their education in various institutions. Keith pursued a Doctor of Public Health degree in Global Health Leadership at Indiana University-Purdue University Indianapolis. Keith also earned a Master of Science degree specializing in Information Management from Aspen University. Furthermore, they obtained a Master of Business Administration degree specializing in Information Management, also from Aspen University. Lastly, Keith earned a Bachelor of Arts degree in Communications with a specialization in Public Relations and Advertising from Seton Hall University.